Unravelling the mosaic: Epigenetic diversity in glioblastoma
Molecular Oncology · 2024-12 · 18 (12) · 2871-2889
DOI: 10.1002/1878-0261.13706 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 15.08.2024. Verfasst von Sara Lucchini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumour Research Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, UK. Hauptthemen laut MEDLINE: Glioblastoma, Epigenesis, Genetic, DNA Methylation, Brain Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Tumour Research, Barts Charity, Cancer Research UK.
Abstract (Originalsprache)
Glioblastoma is the most common primary malignant brain tumour. Despite decades of intensive research in the disease, its prognosis remains poor, with an average survival of only 14 months after diagnosis. The remarkable level of intra‐ and interpatient heterogeneity is certainly contributing to the lack of progress in tackling this tumour. Epigenetic dysregulation plays an important role in glioblastoma biology and significantly contributes to intratumour heterogeneity. However, it is becoming increasingly clear that it also contributes to intertumour heterogeneity, which historically had mainly been linked to diverse genetic events occurring in different patients. In this review, we explore how DNA methylation, chromatin remodelling, microRNA (miRNA) dysregulation, and long noncoding RNA (lncRNA) alterations contribute to intertumour heterogeneity in glioblastoma, including its implications for advanced tumour stratification, which is the essential first step for developing more effective patient‐specific therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Tumour Research Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, UK.
- Barts Brain Tumour Centre, Faculty of Medicine and Dentistry, Queen Mary University of London, UK.
- Barts Health NHS Trust, London, UK.
ORCID-Profile: Silvia Marino
Förderung
- Brain Tumour Research
- Barts Charity
- Cancer Research UK
Zitieren
APA
Lucchini, S., Constantinou, M., & Marino, S. (2024). Unravelling the mosaic: Epigenetic diversity in glioblastoma. Molecular Oncology, 18(12), 2871-2889. https://doi.org/10.1002/1878-0261.13706
Vancouver
Lucchini S, Constantinou M, Marino S. Unravelling the mosaic: Epigenetic diversity in glioblastoma. Molecular Oncology. 2024;18(12):2871-2889. doi:10.1002/1878-0261.13706
BibTeX
@article{Lucchini2024,
author = {Lucchini, Sara and Constantinou, Myrianni and Marino, Silvia},
title = {Unravelling the mosaic: Epigenetic diversity in glioblastoma},
journal = {Molecular Oncology},
year = {2024},
volume = {18},
number = {12},
pages = {2871--2889},
doi = {10.1002/1878-0261.13706}
}
EUVIMED